載入...
Drinking from the fountain of promise: biomarkers in the surveillance of Barrett's oesophagus—the glass is half full!
Biomarkers for prognostication need large randomised controlled trials such as AspECT and BOSS. These trials will deliver surrogates which fulfil the validation criteria necessary for their introduction into the clinic
Na minha lista:
Main Authors: | , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
BMJ Group
2006
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1856442/ https://ncbi.nlm.nih.gov/pubmed/16966694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2006.096461 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|